WHO issues validation for a COVID-19 vaccine

validation for a COVID-19 vaccine

WHO issues its first emergency use validation for a COVID-19 vaccine and emphasizes need for equitable global access: The World Health Organization (WHO) today listed the Comirnaty COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago. The WHO’s Emergency […]

Read More… from WHO issues validation for a COVID-19 vaccine

What is the scale of COVID-19 vaccine scepticism?

vaccine

COVID-19 Series: What is the scale of vaccine scepticism? – Episode 56 Webinar: Date and time: Thu 7 Jan 2021 from 12:30pm to 1:15pm Register to join Episode 56 ‘What is the scale of vaccine scepticism?’ on Zoom here. Following the rapid development of vaccines for COVID-19, successful vaccine delivery will be the most important factor […]

Read More… from What is the scale of COVID-19 vaccine scepticism?

Lasting Power of Attorney and the Covid vaccine

refuse the Covid vaccine

Do I have the right to refuse the Covid vaccine on behalf of a relative? The requirement for an Lasting Power of Attorney (LPA) to navigate the welfare of a venerable loved one is discussed here by Chris Partington, Partner and Head of Private Client at Slater Heelis: Over the coming weeks, the first 800,000 […]

Read More… from Lasting Power of Attorney and the Covid vaccine

Update on The University of Queensland COVID-19 vaccine

strong support

Friday, 11th December, 2020: The University of Queensland (UQ) and CSL today announce that the Phase 1 trial of the UQ-CSL v451 COVID-19 vaccine has shown that it elicits a robust response towards the virus and has a strong safety profile. There were no serious adverse events or safety concerns reported in the 216 trial participants. However, […]

Read More… from Update on The University of Queensland COVID-19 vaccine

Less than 50% willing to get a COVID-19 vaccine

willing to get a COVID-19 vaccine

Less than half of people currently willing to get a COVID-19 vaccine, international survey suggests: A new report on the public’s attitudes towards coronavirus vaccines has revealed that around half of those surveyed (51%) may be willing to get vaccinated next year.  Findings from a survey of 13,500 people across 15 countries* in November suggest that […]

Read More… from Less than 50% willing to get a COVID-19 vaccine

Safety paramount to COVID-19 vaccine programme

vaccine

Comment from Royal Pharmaceutical Society: safety of staff and patients paramount to the COVID-19 vaccine programme: Following the news that the Medicines and Healthcare products Regulatory Agency (MHRA) has approved the Pfizer/BioNTech COVID-19 vaccine for rollout in the UK from next week, we are calling for the safety of pharmacy teams and their patients to […]

Read More… from Safety paramount to COVID-19 vaccine programme

Oxford University’s COVID-19 vaccine is effective

The interim phase III trial results are in: Oxford University’s COVID-19 vaccine is effective. Find out more about this story: ttps://www.ox.ac.uk/news/2020-11-23-oxford-university-breakthrough-global-covid-19-vaccine Transcript The Oxford Covid-19 vaccine is highly effective, according to new data released today. In trial run on more than 20,000 people across the world, interim data show the vaccine is 70.4% effective, and […]

Read More… from Oxford University’s COVID-19 vaccine is effective

Fiji’s vaccine program reduces childhood death and illness: study

Fiji's national vaccine program

Fiji’s national vaccine program against pneumonia, a serious lung condition, and rotavirus, a common disease which causes severe diarrhoea and vomiting, has reduced illness and death, new research shows. The University of Melbourne-led research team, which worked with the Fiji Ministry of Health and Medical Services, says the results underline the importance of vaccines and […]

Read More… from Fiji’s vaccine program reduces childhood death and illness: study

Wealthy countries hoarding breakthrough vaccines

countries

AMNESTY INTERNATIONAL: Wealthy countries already hoarding breakthrough vaccines Responding to the announcement by Pfizer-BioNTech that the COVID-19 vaccine it is developing has been found to be effective in 90 percent of people, Tamaryn Nelson, Amnesty International’s Researcher on the Right to Health, said: “It is great news that the Pfizer-BioNTech vaccine is proving effective against […]

Read More… from Wealthy countries hoarding breakthrough vaccines

COVID-19 Series: Vaccines and living with the virus – Episode 50

vaccine

This episode of the COVID-19 Series will feature an interview with Sir Jeremy Farrar, Director of the Wellcome Trust. In an interview with Professor Sir Simon Wessely, the two will discuss topics including the latest news on vaccines, international developments, if it is possible for governments to really “follow the science”, and whether we can live with […]

Read More… from COVID-19 Series: Vaccines and living with the virus – Episode 50